Literature DB >> 8777933

Severe carbamazepine toxicity induced by concurrent erythromycin therapy.

C R Mota, C Carvalho, C Mota, P Ferreira, A Vilarinho, E Pereira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8777933     DOI： 10.1007/bf02002727

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  4 in total

1.  Severe carbamazepine intoxication after coadministration of erythromycin.

Authors:  K J Goulden; P Camfield; J M Dooley; A Fraser; D C Meek; K W Renton; J A Tibbles
Journal:  J Pediatr       Date:  1986-07       Impact factor: 4.406

2.  Carbamazepine toxicity induced by concurrent erythromycin therapy.

Authors:  E Carranco; J Kareus; S Co; V Peak; S Al-Rajeh
Journal:  Arch Neurol       Date:  1985-02

3.  Carbamazepine poisoning in children.

Authors:  A J Macnab; P Birch; J Macready
Journal:  Pediatr Emerg Care       Date:  1993-08       Impact factor: 1.454

4.  Erythromycin-induced drug interactions. An illustrative case and review of the literature.

Authors:  B J Zitelli; D L Howrie; H Altman; T J Maroon
Journal:  Clin Pediatr (Phila)       Date:  1987-03       Impact factor: 1.168
  4 in total
  3 in total

Review 1.  Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Authors:  F Pea; M Furlanut
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

2.  Role of cytochrome P450 in drug interactions.

Authors:  Zakia Bibi
Journal:  Nutr Metab (Lond)       Date:  2008-10-18       Impact factor: 4.169

3.  Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4.

Authors:  Shufeng Zhou; Eli Chan; Xiaotian Li; Min Huang
Journal:  Ther Clin Risk Manag       Date:  2005-03       Impact factor: 2.423
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.